Related references
Note: Only part of the references are listed.A Promising Therapeutic Target for Metabolic Diseases: Neuropeptide Y Receptors in Humans
Min Yi et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Is NPY causing myocardial ischemia in patients with microvascular angina associated with its abnormal constrictor response at the microcirculation level?
Yuwei Zhao et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Effects of neuropeptide Y on coronary artery vasomotion in patients with microvascular angina
Giuseppe M. C. Rosano et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
NPY Impairs Cell Viability and Mitochondrial Membrane Potential Through Ca2+ and p38 Signaling Pathways in Neonatal Rat Cardiomyocytes
Jun Hu et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2017)
Different effects of neuropeptide Y on proliferation of vascular smooth muscle cells via regulation of Geminin
Zhou-qin Jiang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2017)
Role of sympathetic cotransmitter galanin on autonomic balance in heart failure: an active player or a bystander?
Demet Ozkaramanli Gur et al.
ANATOLIAN JOURNAL OF CARDIOLOGY (2017)
The role of neuropeptides in adverse myocardial remodeling and heart failure
Alexander Widiapradja et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
The glucagon-like peptide-1 analogue exendin-4 reverses impaired intracellular Ca2+ signalling in steatotic hepatocytes
Eunues S. Ali et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Neuropeptide Y is an angiogenic factor in cardiovascular regeneration
Rabya Saraf et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
The role of neuropeptide Y in the pathophysiology of atherosclerotic cardiovascular disease
Ping Zhu et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Protection against ventricular fibrillation via cholinergic receptor stimulation and the generation of nitric oxide
Manish Kalla et al.
JOURNAL OF PHYSIOLOGY-LONDON (2016)
Elevated levels of neuropeptide Y in preeclampsia: A pilot study implicating a role for stress in pathogenesis of the disease
Sara P. C. Paiva et al.
NEUROPEPTIDES (2016)
Association of neuropeptide Y promoter polymorphism (rs16147) with perceived stress and cardiac vagal outflow in humans
Hsin-An Chang et al.
SCIENTIFIC REPORTS (2016)
NPY1-36 and PYY1-36 activate cardiac fibroblasts: an effect enhanced by genetic hypertension and inhibition of dipeptidyl peptidase 4
Xiao Zhu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2015)
Long-Term Administration of Neuropeptide Y in the Subcutaneous Infusion Results in Cardiac Dysfunction and Hypertrophy in Rats
Rang Zhang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Neuropeptide Y receptor mediates activation of ERK1/2 via transactivation of the IGF receptor
Sandra Lecat et al.
CELLULAR SIGNALLING (2015)
Neuropeptide Y damages the integrity of mitochondrial structure and disrupts energy metabolism in cultured neonatal rat cardiomyocytes
Guochang Luo et al.
PEPTIDES (2015)
Autonomic control of the heart: going beyond the classical neurotransmitters
Neil Herring
EXPERIMENTAL PHYSIOLOGY (2015)
Neuropeptide Y Stimulates Proliferation and Migration of Vascular Smooth Muscle Cells from Pregnancy Hypertensive Rats via Y1 and Y5 Receptors
Ping Zhang et al.
PLOS ONE (2015)
The anorexic hormone Peptide YY3-36 is rapidly metabolized to inactive Peptide YY3-34 in vivo
Signe Torang et al.
PHYSIOLOGICAL REPORTS (2015)
Role of neuropeptides in cardiomyopathies
Magdalena Chottova Dvorakova et al.
PEPTIDES (2014)
Cardiac sympathetic dysfunction in the prehypertensive spontaneously hypertensive rat
Julia Shanks et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Inflammation and immune system interactions in atherosclerosis
Bart Legein et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Platelet neuropeptide Y is critical for ischemic revascularization in mice
Jason U. Tilan et al.
FASEB JOURNAL (2013)
Relationship of plasma neuropeptide Y with angiographic, electrocardiographic and coronary physiology indices of reperfusion during ST elevation myocardial infarction
Florim Cuculi et al.
HEART (2013)
Neuropeptide Y induces secretion of high-mobility group box 1 protein in mouse macrophage via PKC/ERK dependent pathway
Jiang-Rui Zhou et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Extreme exercise enhances chromogranin A levels correlating with stress levels but not with cardiac burden
T. Nickel et al.
ATHEROSCLEROSIS (2012)
NPY and Stress 30 Years Later: The Peripheral View
Dalay Hirsch et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2012)
Pre-eclampsia and offspring cardiovascular health: mechanistic insights from experimental studies
Esther F. Davis et al.
CLINICAL SCIENCE (2012)
Abnormal Intracellular Calcium Homeostasis in Sympathetic Neurons From Young Prehypertensive Rats
Dan Li et al.
HYPERTENSION (2012)
Role of neuropeptide Y and peroxisome proliferator-activated receptor γ coactivator-1α in stress cardiomyopathy
Sunnassee Ananda et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2012)
Neuropeptide Y improves myocardial perfusion and function in a swine model of hypercholesterolemia and chronic myocardial ischemia
Robina Matyal et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
The cardiac sympathetic co-transmitter galanin reduces acetylcholine release and vagal bradycardia: Implications for neural control of cardiac excitability
Neil Herring et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Prevention of Vascular Dysfunction after Preeclampsia: A Potential Long-Term Outcome Measure and an Emerging Goal for Treatment
Merzaka Lazdam et al.
JOURNAL OF PREGNANCY (2012)
Chronic type II diabetes mellitus leads to changes in neuropeptide Y receptor expression and distribution in human myocardial tissue
Robina Matyal et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Diabetic neuropathy and heart failure: role of neuropeptides
Asma Ejaz et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2011)
Elevated serum levels of neuropeptide Y in stress cardiomyopathy
Sebastian Szardien et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Of Mice and Men: Neuropeptide Y and Its Receptors Are Associated with Atherosclerotic Lesion Burden and Vulnerability
Lijun Li et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2011)
Therapeutic potential of neuropeptide Y (NPY) receptor ligands
Shaun P. Brothers et al.
EMBO MOLECULAR MEDICINE (2010)
Effects of neuropeptide Y on collateral development in a swine model of chronic myocardial ischemia
Michael P. Robich et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Novel genetic variants contributing to left ventricular hypertrophy: the HyperGEN study
Donna K. Arnett et al.
JOURNAL OF HYPERTENSION (2009)
Sympathetic nervous system-targeted neuropeptide Y overexpression in mice enhances neointimal formation in response to vascular injury
Suvi Ruohonen et al.
PEPTIDES (2009)
Neuropeptide Y Gene Polymorphisms Confer Risk of Early-Onset Atherosclerosis
Svati H. Shah et al.
PLOS GENETICS (2009)
Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension
M. Baltatzi et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway
Neil Herring et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Expression of neuropeptide Y and its receptors Y1 and Y2 in the rat heart and its supplying autonomic and spinal sensory ganglia in experimentally induced diabetes
M. Chottova Dvorakova et al.
NEUROSCIENCE (2008)
Neuropeptide Y promotes TGF-β1 production in RAW264.7 cells by activating PI3K pathway via Y1 receptor
Jiang-Rui Zhou et al.
Neuroscience Bulletin (2008)
Renal and cardiac neuropeptide Y and NPY receptors in a rat model of congestive heart failure
Ean Y. Callanan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Effects of neuropeptide Y2 receptor blockade on ventricular arrhythmias in rats with acute myocardial infarction
Elmir Omerovic et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Autonomic modulation of electrical restitution, alternans and ventricular fibrillation initiation in the isolated heart
G. Andre Ng et al.
CARDIOVASCULAR RESEARCH (2007)
NPY and NPY receptors in vascular remodeling
Ken Abe et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
Neuropeptide Y (NPY) and NPY receptors in the cardiovascular system: implication in the regulation of intracellular calcium
Danielle Jacques et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2007)
NPY and cardiac diseases
B. J. McDermott et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
Modulation of contractile function through neuropeptide Y receptors during development of cardiomyocyte hypertrophy
Adrian R. Allen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors
Sharareh Movafagh et al.
FASEB JOURNAL (2006)
Ventricular fibrillation induced by ischemia-reperfusion is not prevented by the NPYY2 receptor antagonist BIIE0246
Arnfinn Ilebekk et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2006)
NPY, ET-1, and Ang II nuclear receptors in human endocardial endothelial cells
Danielle Jacques et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2006)
Chronic stress induces rapid occlusion of angioplasty-injured rat carotid artery by activating neuropeptide Y and its Y1 receptors
LJ Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Influence of endogenous neuropeptide Y (NPY) on the sympathetic-parasympathetic interaction in the canine heart
A Ilebekk et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
Mechanisms of neuropeptide Y, peptide YY, and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus
C Acuna-Goycolea et al.
JOURNAL OF NEUROSCIENCE (2005)
Early dietary intervention: long-term effects on blood pressure, brain neuropeptide Y, and adiposity markers
E Velkoska et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Calmodulin kinase signaling in heart: an intriguing candidate target for therapy of myocardial dysfunction and arrhythmias
ME Anderson
PHARMACOLOGY & THERAPEUTICS (2005)
Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors
J Kitlinska et al.
CANCER RESEARCH (2005)
Neuropeptide Y rapidly enhances [Ca2+](i) transients and Ca2+ sparks in adult rat ventricular myocytes through Y-1 receptor and PLC activation
MD Heredia et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
Diabetes mellitus and heart failure: basic mechanisms, clinical features, and therapeutic considerations
TD Giles et al.
CARDIOLOGY CLINICS (2004)
Neuropeptide Y inhibits acetylcholine release in human heart atrium by activation of Y2-receptors
E Schwertfeger et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2004)
Neuropeptide Y and energy homeostasis: insights from Y receptor knockout models
H Herzog
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Neuropeptide Y-induced acceleration of postangioplasty occlusion of rat carotid artery
LJ Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system?
Z Zukowska et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2003)
Neuropeptide Y: A novel mechanism for ischemic angiogenesis
Z Zukowska et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2003)
Mitogenic actions of neuropeptide Y in vascular smooth muscle cells:: synergetic interactions with the β-adrenergic system
J Pons et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2003)
Neuropeptide Y: the universal soldier
T Pedrazzini et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2003)
Distribution of neuropeptide YY1 and Y2 receptors in the postmortem human heart
AC Jönsson-Rylander et al.
PEPTIDES (2003)
Neuropeptide Y and its receptors as potential therapeutic drug targets
AP Silva et al.
CLINICA CHIMICA ACTA (2002)
Induction of hypertrophic responsiveness of cardiomyocytes to neuropeptide Y in response to pressure overload
D Bell et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies
VJ Dzau et al.
NATURE MEDICINE (2002)
Autonomic neuropathy is associated with impaired pancreatic polypeptide and neuropeptide Y responses to insulin-induced hypoglycaemia in Type I diabetic patients
J Bolinder et al.
DIABETOLOGIA (2002)
Neuropeptide YY1 receptor regulates protein turnover and constitutive gene expression in hypertrophying cardiomyocytes
SM Nicholl et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Neuropeptide Y increases 4-aminopyridine-sensitive transient outward potassium current in rat ventricular myocytes
MP Heredia et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Role of neuropeptide YY2 receptors in modulation of cardiac parasympathetic neurotransmission
MA Smith-White et al.
REGULATORY PEPTIDES (2002)
Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men
MK Karvonen et al.
ATHEROSCLEROSIS (2001)
Acetylcholine release in human heart atrium - Influence of muscarinic autoreceptors, diabetes, and age
V Oberhauser et al.
CIRCULATION (2001)
Neuropeptide Y and the adrenal gland: a review
D Renshaw et al.
PEPTIDES (2001)
Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding
G Ghersi et al.
PEPTIDES (2001)
Neuropeptide Y receptors differentially modulate G-protein-activated inwardly rectifying K+ channels and high-voltage-activated Ca2+ channels in rat thalamic neurons
QQ Sun et al.
JOURNAL OF PHYSIOLOGY-LONDON (2001)
Effects of a selective neuropeptide YY2 receptor antagonist, BIIE0246, on Y2 receptors at peripheral neuroeffector junctions
MA Smith-White et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Ventricular activation during sympathetic imbalance and its computational reconstruction
MP Nash et al.
JOURNAL OF APPLIED PHYSIOLOGY (2001)
Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPYY5 receptors
C Pellieux et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Pathophysiological role of leptin in obesity-related hypertension
M Aizawa-Abe et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
